News & events

News & events

Filter by:
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces it...
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the...
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, has been awarded...
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that...
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the...
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the...
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the...
VarmX, Leiden based biotech company focusing on the development of therapies in the field of hemostasis and thrombosis, today...
VarmX announces publication in Nature Communications of groundbreaking snake venom inspired approach to restore blood clotting in patients using...

VMX-C001: Transforming the treatment of bleeding in patients taking Factor Xa DOACs